Alexander S. Partsernyak

Alexander S. Partsernyak

Auto-generated profile, based on publicly available information

Alexander S. Partsernyak

Kirov Military Medical Academy

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2021 in Bulletin of the Russian Military Medical Academy
Verified
Journal Article
Open access
PDF file
APAlexander S. Partsernyak
Alexander S. Partsernyak
EKEvgeny V. Kryukov
Evgeny V. Kryukov
VTVasily N. Tsygan
Vasily N. Tsygan
EKEvgeny S. Kurasov
Evgeny S. Kurasov
DODmitrii V. Ovchinnikov
Dmitrii V. Ovchinnikov
ЦНЦыган Василий Николаевич
Цыган Василий Николаевич
The peculiarities of the influence of the metabolic disorders and depressive spectrum disorders in the development of polymorbid pathology are investigated. 160 male patients were examined, divided into three groups. The first group included 56 young men, 3940.2 years old, body mass index 34.235 kg/m2, suffering from the polymorbid cardiovascular pathology, in which the presence of coronary heart disease, angina pectoris of the functional class III, arterial hypertension 23 degrees, obesity 12 degrees, depressive spectrum disorders was considered. The second group included 56 middle-aged men, 47.548.3 years old, body mass index 36.236.9 kg/m2 with a similar combination of diseases of the first group. The third (control group) included 48 young men, 39.640.9 years old, body mass index 24.124.9 kg/m2, suffering from the polymorbid cardiovascular pathology without the metabolic syndrome and obesity. The anthropometric status, glucose, insulin, total cholesterol, triglycerides, and low-density lipoproteins were assessed. Instrumental diagnostics of the coronary heart disease and hypertension was carried out, anxiety and depressive disorders were established based on the results of a questionnaire and a consultation with a psychiatrist. It was found that in a group of young and middle-aged patients suffering from the polymorbid cardiovascular pathology, in combination with a metabolic syndrome and depressive spectrum disorders, psychopathological disorders (borderline anxiety-depressive state) are associated with the metabolic disorders, high prevalence of pain-free form of myocardial ischemia and unfavorable variants of two-phase blood pressure rhythm during the day, according to the type of insufficient degree of reduction of nocturnal blood pressure non-dippers and a steady increase in the night blood pressure night-peakers, which determines a high risk of cardiovascular complications.

1 January 2021 in Cardiology: News, Opinions, Training
Verified
Journal Article
Closed access
ILI.A. Lebedeva
I.A. Lebedeva
NFNorth-Western State Medical University named after I.I. Mechnikova of the Ministry of Health of the Russian Federation
North-Western State Medical University named after I.I. Mechnikova of the Ministry of Health of the Russian Federation
GMG.N. Magradze
G.N. Magradze
SPS.A. Partsernyak
S.A. Partsernyak
VUV.S. Ustyuzhaninov
V.S. Ustyuzhaninov
S4Saint-Petersburg City Hospital No. 40
Saint-Petersburg City Hospital No. 40

18 December 2023 in Experimental and Clinical Gastroenterology
Verified
Journal Article
Open access
PDF file
KBK. I. Bulgar
K. I. Bulgar
IPI. M. Pavlovich
I. M. Pavlovich
APA. S. Parcernyak
A. S. Parcernyak
BCB. A. Chumak
B. A. Chumak
Helicobacter pylori (H. pylori) is one of the most common infections worldwide. According to modern ideas, it is the main cause of a number of diseases of the stomach and duodenum (peptic ulcer, chronic gastritis, MALT lymphoma) and the leading risk factor for stomach cancer. In the hospital therapy clinic of the Kirov Military Medical Academy, we observed 118 patients. The study groups included patients with various types of chronic gastritis (atrophic and non-atrophic). The patients were comparable in gender and age. Infection H. pylori was verified in 22 patients (68.8%) suffering from chronic non-atrophic gastritis and in 34 patients (37.2%) suffering from chronic atrophic gastritis. In the course of the study, the relationship between the contamination of H. pylori and the presence of dysregenerative changes in the gastric mucosa was evaluated. It was found that H. pylori infection does not significantly affect the development and progression of atrophy in the mucous membrane of the antrum of the stomach. Also, no convincing data on the effect of H. pylori on dysregenerative processes (intestinal metaplasia and dysplasia) in the gastric mucosa. At the same time, the presence of pathogenicity factors H. pylori Vac A and Cag A significantly affects the progression of atrophic changes in the gastric mucosa. At the stage of formed atrophy, the intensity of H. pylori invasion is significantly reduced.

1 January 2021 in Cardiology: News, Opinions, Training
Verified
Journal Article
Closed access
NFNorth-Western State Medical University named after I.I. Mechnikova of the Ministry of Health of the Russian Federation
North-Western State Medical University named after I.I. Mechnikova of the Ministry of Health of the Russian Federation
ILI.A. Lebedeva
I.A. Lebedeva
GMG.N. Magradze
G.N. Magradze
S1Saint-Petersburg City Hospital No. 15
Saint-Petersburg City Hospital No. 15
SPS.A. Partsernyak
S.A. Partsernyak
MFMilitary Medical Academy Named After S.M. Kirov Of The Ministry Of Defence Of The Russian Federation
Military Medical Academy Named After S.M. Kirov Of The Ministry Of Defence Of The Russian Federation
Оценка прогнозирования сердечно-сосудистых рисков у лиц с артериальной гипертензией и воспалительными процессами ротовой полости

28 September 2022 in Frontiers in Neuroscience
Verified
Journal Article
Open access
APAlexander S. Partsernyak
Alexander S. Partsernyak
VPVictoria O. Polyakova
Victoria O. Polyakova
ATArtem G. Trufanov
Artem G. Trufanov
DMDmitriy S. Medvedev
Dmitriy S. Medvedev
DTDina V. Trotsyuk
Dina V. Trotsyuk
AKAlexander S. Krasichkov
Alexander S. Krasichkov
Objectives: To investigate the relationship between changes in circadian patterns of melatonin and clinical manifestations of polymorbid cardiovascular pathology (PCVP) in young men and to analyze the effectiveness of their complex treatment.Materials and methods: We made the immunohistochemical (IHC) analysis of epiphysis tissues from autopsies of 25 men aged 32–44 with PCVP and metabolic syndrome (MS) who had died as a result of ischemic cardiomyopathy (IC) and 25 persons after the car accident as a control group. Then, 93 young men aged 35–44 with PCVP, metabolic syndrome, and depressive spectrum disorders (DSD) were divided into three groups: (1) standard therapy; (2) standard therapy and psychotherapy sessions; (3) standard therapy in combination with psychotherapeutic and psychophysiological visual and auditory correction sessions. The control group included 24 conditionally healthy male volunteers. Before and after the treatment, we studied the anthropometric status, lipid and carbohydrate metabolism indicators, the level of urinary 6-hydroxymelatonin sulfate, the degree of nocturnal decrease in blood pressure (BP), and the relationship of these indicators with circadian variations of melatonin excretion.Results: Young polymorbid patients who died from IC have a lower expression of melatonin type 1 and 2 receptors. All patients with PCVP showed a decrease in the nocturnal melatonin excretion fraction and a correlation with higher severity of depressive (r = −0.72) and anxiety (r = −0.66) symptoms. Reduced values of the 6-hydroxymelatonin sulfate (6-SM) in the 1st (r = 0.45), 2nd (r = 0.39), and 3rd (r = 0.51) groups before treatment was associated with periods of increased BP. The achievement of melatonin excretion reference values and normalization of biochemical parameters of carbohydrate and lipid metabolism, daily BP profile, and psychophysiological state were noted in all three patients’ groups, with a more pronounced effect in group 3.Conclusion: Low nocturnal melatonin excretion levels are associated with greater severity of clinical symptoms and a higher risk of death in patients with PCVP. Therefore, comprehensive therapy may be more effective for correcting this disease.

1 January 2025 in Cardiology: News, Opinions, Training
Verified
Journal Article
Open access
MAMinistry Of Defence Of The Russian Federation S.M. Kirov Military Medical Academy
Ministry Of Defence Of The Russian Federation S.M. Kirov Military Medical Academy
ILI.A. Litovskiy
I.A. Litovskiy
AGA.V. Gordienko
A.V. Gordienko
APA.S. Partsernyak
A.S. Partsernyak
Влияние вазо-, инопрессоров, инодилататоров и нитроглицерина на точку невозврата при кардиогенном шоке